BioSpace News Archive

City of Hope ® to Acquire Cancer Treatment Centers of America ® , Bringing Leading-Edge Cancer Research, Discovery, Compassionate Care and Advanced Treatments to More Patients, Families and Communities Nationwide.

MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Cybersecurity is pleased to announce its role in the granting of the de novo by the U.S. Food and Drug Administration (FDA) for Active Life Scientific, Inc.'s OsteoProbe®.

Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San Antonio Breast Cancer Symposium® (SABCS®) supporting the clinical value of the Oncotype DX Breast Recurrence Score test.

Takeda Canada Inc. has released a Report on the global rare diseases policy landscape at the Forum de l’Industrie de la Santé de Québec.

Emendo Biotherapeutics, a next-generation CRISPR company expanding the reach of gene editing therapeutics, will be presenting a poster at the annual American Society of Hematology conference in Atlanta, taking place December 11-14, 2021.

Growing prevalence of chronic and acute diseases across the globe, increasing volumes of surgical procedures, and increasing use of anticoagulating agents are among the key factors expected to drive market revenue growth over the next few years.

CooperCompanies announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2022, to stockholders of record on January 21, 2022.

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced that stockholders have approved the two proposals voted on at the Company’s Special Meeting of Stockholders held on December 8, 2021.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, will host an Investor Day on Wednesday, December 15, 2021 from 3:00 PM to 6:00 PM ET in New York City.

The rising need to outsource analytical testing services for decreased manufacturing costs and augmented operational efficiency is a key market growth driver.